Crohn's disease (CD) is associated with a higher type-1-helper T cell (Th1) cytokine expression, whereas ulcerative colitis (UC) appears to express a modified Th2 response. In addition to its classic role in calcium homeostasis, calcitriol, the hormonal active form of vitamin D, exerts immunoregulatory effects such as modulation of Th1/Th2 cytokines. Therefore, calcitriol administration could modify immune dysfunction in CD and UC. Nine patients with UC [M/F: 5/4; mean age 47 years, remission(R)/active(A) disease: 7/2], 8 patients with CD [M/F: 2/6; mean age 36, R/A 5/3] and 6 healthy controls (HC) [M/F: 3/3, mean age 46] were enrolled. Peripheral blood was collected after a drug-washout of 15 days and peripheral blood mononuclear cells were stimulated with mitogens alone or in the presence of physiological concentrations of calcitriol (100 pg/ml). Type 1 (IL-2, TNF-α, IFN-γ) and type 2 (IL-10) cytokine production was assayed on supernatants by ELISA. Compared to HC, TNF-α production was significantly higher both in UC (p=0.0002) and CD (p=0.0001) patients, at baseline and after incubation with calcitriol (UC p=0.0003, CD p=0.0009). The effects of calcitriol incubation were: 1) reduced IFN-γ (p=0.024) and increased IL-10 (p=0.06) production in UC patients; 2) reduced TNF-α production in CD (p=0.032); 3) no significant effects in HC. Calcitriol increased, albeit not significantly, IL-10 production in UC compared to CD patients (p=0.09). These results suggest an important modulatory role of vitamin D in the Th1/Th2 immune response. The observation that the effect of this modulation was different in CD compared to UC patients provides an interesting area of research into the pathogenesis and treatment of these inflammatory conditions.
BrownSJMayerL. The immune response in inflammatory bowel disease. Am J Gastroenterol2007; 102:2058–69.
6.
MosmannTRChewinskiHBodMWGiedlinMACoffmannRL. Two types of murine helper T cell clones. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol1986; 3:28–57.
7.
AbbasAKMurphyKMSherA. Functional diversity of helper T lymphocytes. Nature1996; 383:787–93.
8.
TomsCPowrieF. Control of intestinal inflammation by regulatory T cells. Microbes Infect2001; 3:929–35.
9.
PalloneFMonteleoneG. Interleukin 12 and Th1 responses in inflammatory bowel disease. Gut1998; 43:735–6.
10.
PlevySELandersCJPrehnJCarramanzanaNMDeemRLShealyDTarganSR. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J Immunol1997; 159:276–82.
11.
NiessnerMVolkBA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by RT-PCR. Clin Exp Immunol1995; 101:428–35.
12.
FussIJNeurathMBoirivantMKleinJSde la MotteCStrongSAFiocchiCStroberW. Disparate CD4 lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease: CD LP cells manifest increased secretion of IFN-gamma, whereas UC LP cells manifest increased secretion of IL5. J Immunol1996; 157:1261–70.
13.
ArdizzoneSPorroG Bianchi. Biologic therapy for inflammatory bowel disease. Drugs2005; 65:2253–86.
14.
BhallaAKAmentoEPClemensTLHolickMFKraneSM. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: Presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab1983; 7:1308–10.
15.
ProvvediniDMTsoukasCDDeftosLJManolagasSC. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science1983; 221:1181–3.
16.
DelucaHFCantornaMT. Vitamin D: Its role and uses in immunology. FASEB J2001; 15:2579–85.
17.
CantornaMTHayesCEDeLucaHF, 1,25-dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA1996; 93:7861–4.
18.
MathieuCWaerJLaureysJRutgeertsOBouillonR. Prevention of autoimmune diabetes in NOD mice by 1,25-dihydroxyvitamin D3. Diabetologia1994; 37:552–8.
19.
LemireJMInceATakashimaM. 1,25-dihydroxyvitamin D3 attenuates the expression of experimental murine lupus of MLR/1 mice. Autoimmunity1992; 12:143–8.
20.
OverberghLDecallonneBWaerM. 1,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524–543). Diabetes2000; 49:1301–7.
21.
Raush-FanXLeutmezerFWillheimMSpittlerABohleBEbnerCJensen-JarolimEBoltz-NitulescuG. Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific Th cell clones by l-alpha,25-dihydroxyvitamin D3. Int Arch Allergy Immunol2002; 128:33–41.
22.
LimWCHanauerSBLiYC. Mechanisms of disease: Vitamin D and inflammatory bowel disease. Nat Clin Pract Gastroenterol Hepatol2005; 2:308–15.
23.
FroicuMWeaverVWynnTAMcDowellMAWelshJECantornaMT. A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol2003; 17:2386–92.
24.
FroicuMZhuYCantornaMT. Vitamin D receptor is required to control gastrointestinal immunity in IL-10 knockout mice. Immunology2006; 117:310–18.
25.
FroicuMCantornaMT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol2007; 8:5.
26.
KongJZhangZMushMWNingGSunJHartJBissonnetteMLiJC. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol2008; 294:G208–16.
27.
ZhuYMahonBDFroicuMCantornaMT. Calcium and 1alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol2005; 35:217–24.
28.
SimmonsJDMullighanCWelshKIJewellDP. Vitamin D receptor gene polymorphism: Association with Crohn's disease susceptibility. Gut2000; 47:211–14.
29.
CantornaMTMunsickCBemissCMahonBD. 1,25-dihydroxycholecalciferol prevents and ameliorates symptoms of experimental murine inflammatory bowel disease. J Nutr2000; 130:2648–52.
30.
CantornaMTMahonBD. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med2004; 229:1136–42.
31.
SelvarajPChandraGJawaharMSRaniMVRajeshwariDNNarayananPR. Regulatory role of vitamin D receptor gene variants of Bsm I, Apa I, Taq I, and Fok I polymorphisms on macrophage phagocytosis and lymphoproliferative response to mycobacterium tuberculosis antigen in pulmonary tuberculosis. J Clin Immunol2004; 24:523–32.
32.
LiuPTStengerSTangDHModlinRL. Cutting edge: Vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol2007; 79:2060–3.
BestWRBecktelJMSingletonJWKernF. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology1976; 70:439–44.
35.
SeoMOkadaMMaedaKOhK. Correlation between endoscopic severity and the clinical activity index in ulcerative colitis. Am J Gastroenterol1998; 93:2124–9.
36.
BevilacquaMDominguezLJGandoliniGValdesVVagoTRighiniVBarrellaMBarbagalloM. Vitamin D substrate-product relationship in idiopathic hypercalciuria. J Steroid Biochem Mol Biol2008. doi:10.1016/j.jsbmb.2008.08.010.
37.
GascheCScholmerichJBrynskovJ. A simple classification of Crohn's disease: Report of the Working Party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis2000; 6:8–15.
RutgeertsPSandbornWJFeaganBG. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med2005; 353:2462–76.
40.
LemireJMArcherDCBeckLSpiegelbergHL. Immunosuppressive actions of 1,25(OH)2D3: Preferential inhibition of Th1 functions. J Nutr1995; 125:1704S–8S.
41.
Staeva-VieiraTPFeedmanLP. 1,250H2D3 inhibits IFN-g and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol2002; 168:1181–9.
42.
BoonstraABarratFJCrainCHeathVLSavelkoulHFO'GarraA. 1,250H2D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J Immunol2001; 167:4974–80.
43.
PennaGRoncariAAmuchasteguiSDanielKCBertiEColonnaMAdoriniL. Expression of the inhibitory receptor ILT3 on dendritic cells is indispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood2005; 106:3490–7.
44.
DanielCSartoryNAZahnNRadekeHHSteinJM. Immune modulatory treatment of TNBS colitis with calcitriol is associated with a change of a Th1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther2008; 324:23–33.
45.
StioMTrevesCMartinesiMd'AlbasioGBagnoliSBonanomiAG. Effect of anti-TNF therapy and vitamin D derivatives on the proliferation of peripheral blood mononuclear cells in Crohn's disease. Dig Dis Sci2004; 49:328–35.
46.
RaedlerASchreiberSde WeerthAVossAPetersSGretenH. Assessment of in vivo activated T cells in patients with Crohn's disease. Hepatogastroenterol1990; 37:67–71.
